Live feed07:30:00·293dPRReleasevia QuantisnowRezolute Announces Alignment with FDA on Streamlined Design for Ongoing Phase 3 Trial of Ersodetug in Tumor HyperinsulinismByQuantisnow·Wall Street's wire, on your screen.RZLT· Rezolute Inc.Health Care
